Dow Up0.08% Nasdaq Down0.30%

Titan Pharmaceuticals Inc. (TTNP)

-OTC BB
0.56 Up 0.01(2.73%) Sep 19, 3:58PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 912   911   911   2,198  
Cost of Revenue -   -   -   -  
Gross Profit 912   911   911   2,198  
Operating Expenses
Research Development749  949  929  1,679  
Selling General and Administrative713  896  624  647  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (550) (934) (642) (128)
Income from Continuing Operations
Total Other Income/Expenses Net(292)(870)433  (1,018)
Earnings Before Interest And Taxes(842)(1,804)(209)(1,146)
Interest Expense -   -   -  (1)
Income Before Tax(842)(1,804)(209)(1,145)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(842)(1,804)(209)(1,145)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (842) (1,804) (209) (1,145)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (842) (1,804) (209) (1,145)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.